HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catherine Butori Selected Research

Neoplasms (Cancer)

11/2018Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients.
9/2018Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.
1/2018Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients.
11/2017Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.
8/2017MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma.
12/2016PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome.
5/2016MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.
1/2016High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
10/2014Extragestational βHCG secretion due to an isolated lung epithelioid trophoblastic tumor: microsatellite genotyping of tumoral cells confirmed their placental origin and oriented specific chemotherapy.
7/2011[Salivary gland tumors in children].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Catherine Butori Research Topics

Disease

14Neoplasms (Cancer)
11/2018 - 08/2006
4Melanoma (Melanoma, Malignant)
11/2018 - 05/2014
3Lung Neoplasms (Lung Cancer)
03/2018 - 02/2011
3Carcinoma (Carcinomatosis)
01/2017 - 11/2009
3Thyroid Neoplasms (Thyroid Cancer)
05/2016 - 06/2006
3Papillary Thyroid Cancer
05/2014 - 11/2009
2Adenocarcinoma of Lung
09/2018 - 11/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 02/2015
2Squamous Cell Carcinoma of Head and Neck
08/2017 - 01/2017
2Circulating Neoplastic Cells
01/2016 - 02/2011
1Hutchinson's Melanotic Freckle (Lentigo Maligna)
01/2020
1Pleural Effusion (Pleural Effusions)
01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2016
1Nevus (Nevi)
01/2016
1Hyperglycemia
12/2014
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
10/2014
1Choriocarcinoma
10/2014
1Trophoblastic Neoplasms (Trophoblastic Tumor)
10/2014
1Alopecia Areata
07/2014
1Alopecia (Baldness)
07/2014
1Lipomatosis
09/2012
1Mycoses (Diseases, Fungus)
01/2010
1Aspergillosis
01/2010
1Mucormycosis
01/2010
1Hyperplasia
11/2009
1Granuloma
12/2006
1Tuberculosis (Tuberculoses)
12/2006
1Acquired Immunodeficiency Syndrome (AIDS)
12/2006

Drug/Important Bio-Agent (IBA)

5Formaldehyde (Formol)FDA Link
11/2017 - 12/2006
4ParaffinIBA
11/2017 - 12/2006
3MicroRNAs (MicroRNA)IBA
08/2017 - 09/2012
2Biomarkers (Surrogate Marker)IBA
03/2018 - 02/2011
2Indicators and Reagents (Reagents)IBA
08/2017 - 12/2016
2Monoclonal AntibodiesIBA
12/2016 - 05/2015
2DNA (Deoxyribonucleic Acid)IBA
05/2014 - 12/2006
13-ingenyl angelateIBA
01/2020
1Cell-Free Nucleic AcidsIBA
11/2018
1Circulating Tumor DNAIBA
11/2018
1pembrolizumabIBA
01/2018
1N 30IBA
01/2018
1Cetuximab (Erbitux)FDA Link
08/2017
1CollagenIBA
01/2017
1Fibronectins (Fibronectin)IBA
01/2017
1oncofetal fibronectinIBA
01/2017
1Immune Checkpoint InhibitorsIBA
12/2016
1cyclohexane- 1,2,4- tris(methylenesulfonate) (CTMS)IBA
01/2016
1Matrix Metalloproteinases (MMPs)IBA
01/2016
1Mitogen-Activated Protein KinasesIBA
05/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2015
1Glucose (Dextrose)FDA LinkGeneric
12/2014
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
10/2014
1SaltsIBA
07/2014
1Interleukin-2 (IL2)IBA
07/2014
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
07/2014
1Imatinib Mesylate (Gleevec)FDA Link
05/2014
1antineoplaston A10 (A 10)IBA
07/2011
1Proteins (Proteins, Gene)FDA Link
01/2010
1Fixatives (Pickling Agents)IBA
11/2009
1Uridine Monophosphate (UMP)IBA
07/2009
1Eosine Yellowish-(YS) (Eosin)IBA
12/2006
1Hematoxylin (Haematoxylon)IBA
12/2006
112E7 AntigenIBA
08/2006
1VimentinIBA
08/2006

Therapy/Procedure

4Therapeutics
11/2018 - 04/2010
2Immunotherapy
09/2018 - 04/2016
2Drug Therapy (Chemotherapy)
10/2014 - 07/2011
1Operative Surgical Procedures
10/2014
1Adjuvant Radiotherapy
07/2011
1Lasers (Laser)
12/2006
1Highly Active Antiretroviral Therapy (HAART)
12/2006
1Thyroidectomy
06/2006